Evolving techniques for gene fusion detection in soft tissue tumours.

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Chromosomal rearrangements leading to gene fusions occur in ~20% of human neoplasms.
• Over 1000 gene fusions are documented, with nearly 100 found in soft tissue tumors.
• Gene fusions significantly influence tumorigenesis and serve as valuable diagnostic markers due to their association with specific tumor subtypes.

Purpose of the Study:

• To highlight the role of gene fusions in tumorigenesis.
• To discuss the evolution of gene fusion detection methods.
• To emphasize the impact of next-generation sequencing (NGS) on identifying novel gene fusions.

Main Methods:

• Traditional methods involved molecular cytogenetics, chromosome banding analysis, reverse transcriptase-polymerase chain reaction (RT-PCR), and Sanger sequencing.
• Next-generation sequencing (NGS) technologies, including whole transcriptome sequencing, have revolutionized gene fusion detection.
• NGS enables the identification of a significantly larger number of novel gene fusions.

Main Results:

• Gene fusions are implicated in the development of various human cancers.
• NGS has led to the discovery of numerous previously unknown gene fusions.
• The diagnostic utility of gene fusions is well-established.

Conclusions:

• Gene fusions are critical players in cancer development and progression.
• NGS technologies are rapidly advancing the field of gene fusion discovery.
• NGS is poised to become a standard clinical tool for cancer diagnosis and research.